Craft

Metagenomi

Stock Price

$2

2024-10-29

Market Capitalization

$74.5 M

2024-10-29

Revenue

$25.2 M

FY, 2025

Metagenomi Summary

Company Summary

Overview
Metagenomi is a company that provides a metagenomics discovery platform. It offers cellular machinery sourced from organisms, its adaptation, and transformation into therapeutic tools for use in treating genetic diseases.
Type
Public
Status
Active
Founded
2018
HQ
Emeryville, CA, US | view all locations
Website
https://metagenomi.co/
Cybersecurity rating
Sectors

Key People

  • Alan Brooks

    Alan Brooks, Head of Preclinical

    • Jian Irish

      Jian Irish, Chief Operating Officer, President, and Director

      • Simon Harnest, Chief Investment Officer and SVP of Strategy

        • Christopher Brown

          Christopher Brown, Head of Discovery

          LocationsView all

          1 location detected

          • Emeryville, CA HQ

            United States

            5959 Horton St FL 7

          Metagenomi Financials

          Summary Financials

          Revenue (Q1, 2026)
          $1.2M
          Net income (Q1, 2026)
          ($23.1M)
          Cash (Q1, 2026)
          $25.3M
          EBIT (Q1, 2026)
          ($24.6M)
          Enterprise value
          $88.4M

          Footer menu